US Patent Issued to EpicentRx on Aug. 6 for "Immunomodulatory fusion proteins" (California Inventors)

  • Christopher Larson

Press/Media

Period7 Aug 2024

Media coverage

1

Media coverage

  • TitleUS Patent Issued to EpicentRx on Aug. 6 for "Immunomodulatory fusion proteins" (California Inventors)
    Media name/outletUS Fed News
    Country/TerritoryUnited States
    Date7/08/24
    PersonsChristopher Larson